AFMS partners with well-known manufacturers to provide a broad portfolio of disease control assays alongside robust platforms for Viral Infectious Diseases, Bacterial Infectious Diseases, COVID-19 Assays, Parasitic Infections, Sexually Transmitted Diseases (STDs) and more.
A game-changing platform that brings laboratory-quality PCR testing to the point of care with Cepheid's growing CLIA waived menu. Reduced footprint with built-in barcode scanner and full-size touchscreen. Cepheid’s GeneXpert® Xpress system combines speed, accuracy, and flexibility to deliver unmatched results at the point of care.
This single, easy-to-use, portable Instrument has a simple and consistent workflow for all tests and is designed for intuitive use - simply follow the on-screen video display for high-sensitivity results in minutes.
Innovative microfluidic technology delivers exceptional clinical performance in minutes, used with the LumiraDx SARS-CoV-2 Test menu;
The QIAstat-Dx Analyzer from QIAGEN, combined with QIAstat-Dx assay cartridges uses real-time PCR to detect pathogen nucleic acids in human biological samples. The QIAstat-Dx Analyzer and cartridges are designed as a closed system containing all necessary reagents on board, enabling hands-off sample preparation.
QIAstat-Dx simplifies infectious disease diagnostics so you can get faster results for your patients. All you need are a patient sample, a QIAstat-Dx assay cartridge and the intuitive QIAstat-Dx instrument.
Salah Alden Road | Al Zahra District
Riyadh | Kingdom of Saudi Arabia
60001 Riyadh 11545
